ARTICLE
Received 6 Apr 2015 | Accepted 17 Jun 2015 | Published 31 Jul 2015
Ying Fan1,2,*, Wenzhen Xiao1,2,*, Zhengzhe Li1, Xuezhu Li1, Peter Y. Chuang1, Belinda Jim3, Weijia Zhang1, Chengguo Wei1, Niansong Wang2, Weiping Jia2, Huabao Xiong4, Kyung Lee1 & John C. He1
Identication of new biomarkers and drug targets for chronic kidney disease (CKD) is required for the development of more effective therapy. Here we report an association between expression of reticulon 1 (RTN1) and severity of CKD. An isoform-specic increase in the expression of RTN1A is detected in the diseased kidneys from mice and humans, and correlates inversely with renal function in patients with diabetic nephropathy. RTN1 over-expression in renal cells induces ER stress and apoptosis, whereas RTN1 knockdown attenuates tunicamycin-induced and hyperglycaemia-induced ER stress and apoptosis. RTN1A interacts with PERK through its N-terminal and C-terminal domains, and mutation of these domains prevents this effect on ER stress. Knockdown of Rtn1a expression in vivo attenuates ER stress and renal brosis in mice with unilateral ureteral obstruction, and also attenuates ER stress, proteinuria, glomerular hypertrophy and mesangial expansion in diabetic mice. Together, these data indicate that RTN1A contributes to progression of kidney disease by inducing ER stress.
DOI: 10.1038/ncomms8841 OPEN
RTN1 mediates progression of kidney disease by inducing ER stress
1 Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York 10029, USA. 2 Department of Nephrology, Shanghai Jiao Tong University Afliated Sixth Peoples Hospital, Shanghai 200233, China. 3 Division of Nephrology, Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA. 4 Immunology Institute, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, 10029, USA. * These authors contributed equally to this work. Correspondence and requests for materials should be addressed to J.C.H. (email: mailto:[email protected]
Web End [email protected] ).
NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 1
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841
Chronic kidney disease (CKD) affects B10% of US adults. The incidence and prevalence of this condition are increasing worldwide1. Therapeutic options for CKD are
limited and at best only offer partial protection against disease progression24. Therefore, there is an urgent need to identify key mediators of CKD progression for the development of more effective therapy to halt its progression.
In this study, to identify such potential mediators, we proled the renal gene expression of a murine model of HIV-associated nephropathy (HIVAN), which has progressive CKD. Genes whose level of expression correlated with severity of renal injury were identied and among them was Rtn1, which encodes for an endoplasmic reticulum (ER)-associated protein called reticulon 1 (RTN1). The reticulon family has four members: RTN1, RTN2, RTN3 and RTN4. Reticulons were rst described in neuroendocrine cells and their function is implicated in neurodegenerative diseases. They localize primarily to the ER membrane as ER-shaping proteins. Reticulons are known to induce apoptosis, inhibit axon regeneration and regulate protein trafcking59. The human RTN1 gene has three transcript variants that encode for three RTN1 isoforms: RTN1A, RTN1B and RTN1C. While the function of RTN1 has been shown to be involved in endocytosis10, apoptosis, and regulation of ER stress and DNA damage-induced cell death11,12, the mechanism by which RTN1 exerts these effects is not known and its structurefunction relationship has not yet been characterized. In addition, RTN1 has never been studied in the context of kidney disease. In the current study, we report that the expression of RTN1, specically RTN1A isoform, is highly upregulated in both human and mouse models with kidney disease, and that its increased expression induces ER stress response and apoptosis in renal cells. Reduction of RTN1A expression in vivo results in attenuation of renal brosis and diabetic kidney injury, which is associated with decreased ER stress markers, indicating that RTN1A is a novel mediator of CKD progression that promotes renal injury through ER stress.
ResultsIdentication of RTN1 as a highly upregulated gene in CKD. To identify genes that contribute to the development of CKD, we examined the renal gene expression of mice with varying extents of renal injury. Tg26 mice, a CKD model of HIVAN, develop signicant proteinuria at 4 weeks of age. Most Tg26 mice do not survive past 36 months of age due to rapidly progressive renal failure. However, some Tg26 mice have milder kidney injury with stable renal function. The kidney histology of Tg26 mice is characterized by collapsing focal segmental glomerulosclerosis and signicant tubular interstitial inammation and brosis with tubular atrophy and dilatation13. To identify genes that are differentially regulated and potentially responsible for the severity of CKD in Tg26 mice, we compared the kidney transcriptomes of Tg26 mice having mild and severe kidney disease with gender-matched wild-type (WT) littermates (Supplementary Table 1). Cluster analysis of differentially expressed genes was performed among these three groups of mice by analysis of variance (ANOVA). Differentially expressed genes were then further grouped based on the patterns of change into ve clusters (Supplementary Fig. 1). Cluster 5 contains a set of genes that demonstrated a pattern where the level of expression correlated with the severity of renal injury (Supplementary Fig. 1; Supplementary Table 2). Several genes in this list are known to be involved in the progression of CKD, such as Prom1 and Tgm2 (refs 14,15).
RTN1 expression correlated inversely with renal function in DN. To ensure candidate genes identied from the Tg26 model were
relevant to human kidney disease, we examined the expression of the genes in cluster 5 in human diseased kidneys by taking advantage of the publically available data sets from Nephromine.org16. We found that RTN1 expression was higher in kidneys of patients with diabetic nephropathy (DN) compared with healthy controls (Supplementary Fig. 2a). Levels of RTN1 messenger RNA (mRNA) transcripts correlated inversely and signicantly with estimated glomerular ltration rate (eGFR) in this DN population (R 0.56, P 7.8 10 5; Supplementary
Fig. 2b). In addition, previous studies in the neurons suggested that RTN1 might be involved in ER stress and apoptosis, which are key pathologic processes leading to the progression of CKD11,12. Therefore, we selected RTN1 as a priority gene for our current study, as its function has never been examined in the context of CKD. To further conrm the relevance of RTN1 in kidney disease, we performed RTN1 immunostaining on kidney biopsy samples of patients with minimal change disease (MCD), DN and HIVAN as well as normal kidney sections of nephrectomy samples. Among three splice variants of RTN1, only RTN1A staining was more pronounced in DN and HIVAN kidney sections compared with MCD and normal kidney sections using an antibody raised against the residues 174337 at the N terminal of RTN1A (Abcam ab8957), which does not recognize RTN1B or RTN1C isoforms. (Fig. 1a,b). The specicity of the staining was conrmed by negative control with IgG and baseline weak staining in the normal kidney. In addition, immunostaining with the antibodies specic for RTN1C did not reveal any changes between normal and diseased kidneys (Supplementary Fig. 3). Overall, RTN1A staining was stronger in the tubular compartment compared with the glomerular compartment. Interestingly, RTN1A staining localized more in the interstitial cells in the HIVAN kidneys compared with the DN kidneys, which may be due to the severe inltration of RTN1A-positive inammatory cells in the HIVAN kidneys. Similarly, in the diabetic kidneys, tissues of some patients had more staining of tubular cells, while others had more staining of interstitial cells (Supplementary Fig. 4). The differential pattern of RTN1A expression is again likely dependent on the severity of tubular cell injury and the degree of inltration of inammatory cells between DN patients. Semi-quantitative assessment of RTN1A staining on kidney sections from 18 patients with DN demonstrated that RTN1A staining intensity in the tubular compartment inversely correlated with eGFR and serum creatinine, while no signicant correlation was observed between glomerular staining and eGFR or serum creatinine (Fig. 1c; Supplementary Table 3; Supplementary Fig. 4). Taken together, these data suggest that both mRNA and protein expression of RTN1A are associated with progression of CKD in humans.
Rtn1a is upregulated in multiple murine models of CKD. We next examined RTN1A expression in multiple murine models of CKD. First, we conrmed that Rtn1a mRNA expression was indeed higher in the kidney cortex and isolated glomeruli of Tg26 mice compared with WT littermates, validating the transcriptome prole analyses (Fig. 2a). RTN1A protein level was also signicantly higher in both the glomerular and tubular compartments of Tg26 mice compared with WT littermates (Fig. 2b,c). Consistent with the human data, we were not able to detect a difference in the expression of RTN1C with isoform-specic antibodies (Supplementary Fig. 5). We also did not detect RTN1B expression in the normal or diseased kidney, suggesting that RTN1B expression might be low or absent in the kidney. We therefore focused on ascertaining the role of RTN1A in kidney disease.
We next examined the renal expression of Rtn1a in the db/db model of DN with a knockout of the endothelial nitric oxide
2 NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841 ARTICLE
a
Normal kidney MCD HIVAN DN
Control-lgG
b
Avg. scores of RTN1 staining
2.5
2
1.5
1
0.5
0
*
*
*
*
Glom Tubule
Normal (n = 7) MCD (n = 5)
DN (n = 18)
HIVAN (n = 5)
c
Score evaluation of RTN1A
staining in kidney glom eruli
1.5
1.0
0.5
0.0
1.5
1.0
0.5
0.0
0.5 1.0 1.5 2.0 2.5
Score evaluation of RTN1
staining in tubular interstitium
3
2
1
0
3
2
1
0.5 1.0 1.5 2.0 2.5
P = 0.0933
R2=0.1660
P =0.0636 R2=0.1988
DN-glom
DN-glom
DN-glom
DN-tubular interstitium
P =0.0003
R2=0.5742
Log eGFR (ml min1 per 1.73 m2) Log eGFR (ml min1 per 1.73 m2)
Score evaluation of RTN1
staining in kidney glom eruli
Score evaluation of RTN1A
staining in tubular interstitium
DN-tubular interstitium
DN-tubular interstitium
P =0.0018
R2=0.4674
0 5 10 15
Scr (mg dl1) Scr (mg dl1)
0 0 5 10 15
Score evaluation of RTN1A
staining in kidney glom eruli
1.5
1.0
0.5
0.0
Score evaluation of RTN1A
staining in tubular interstitium
3
2
1
0
0.0 0.5 1.0 1.5
P =0.0732
R2=0.1869
P =0.0005
R2=0.5417
0.0 0.5 1.5 1.5
Log scr (mg dl1) Log scr (mg dl1)
Figure 1 | Increased RTN1A expression is associated with progression of CKD. (a) Representative immunostaining of RTN1A in kidney sections of patients with minimal change disease (MCD) (n 5), HIVAN (n 5) and diabetic nephropathy (DN) (n 18), as well as in normal kidneys of nephrectomy
samples (n 7). Immunostaining was performed in duplicates. (b) Semi-quantitative scoring of RTN1A staining for both glomerular and tubular interstitial
compartments summarized in a bar graph. *Po0.05, Scale bar, 50 mm. The data were expressed as means.d. The ANOVA with Bonferroni correction was used. (c) Correlation between the intensity of RTN1A staining in glomerular or tubular compartment and renal function (eGFR or serum creatinine) was calculated in patients with DKD using Pearson and Spearman correlation analysis as described in the method. P and R2 are indicated on the graph. n 18.
NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 3
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841
a b
6 Cortex
* *
RTN1 mRNA (fold
changes relative to WT)
changes relative to WT)
Glomeruli
RTN1 mRNA (fold
4 3 2 1 0
RTN 1AGAPDH 37 KD
135 KD
WT
0 WT Tg26
WT
Tg26
Glomeruli
Cortex
c
IgG control
WT
Tg26
Tg26 WT Tg26
d
RTN1 mRNA (fold
changes relative to WT)
4 3 2 1 0
*
WT
db/db;eNOS /
e
IgG control
WT
db/db;eNOS /
Figure 2 | Increased RTN1A in murine CKD models. (a) Rtn1a mRNA expression in the glomeruli (Glom) and kidney cortex (Cortex) of wild-type (WT) and Tg26 mice quantied by qPCR. n 3, *Po0.05, compared with WT group. (b) Western blots of total protein lysates from Glom and Cortex.
Representative blots of three independent experiments are shown. (c) Immunohistochemistry staining of kidney sections from Tg26 and WT control mice and representative images of three mice in each group are shown. Negative control with unrelated IgG is also shown. (d) mRNA expression of Rtn1a in the renal cortices of db/m;eNOS / (WT) and db/db;eNOS / mice as determined by real-time PCR. n 3 for each group. *Po0.05, compared with WT
group. (e) Immunostaining of RTN1A in kidney sections of WTand db/db;eNOS / mice and representative images of three mice in each group as well as negative controls with unrelated IgG are shown. Scale bar, 50 mm. Each PCR experiments were performed in triplicate. Western blot and immunostaining were performed in duplicate. The data were expressed as means.d. The two-sided unpaired t-test was used.
synthase gene (Nos3). These db/db;eNOS / mice were killed at age of 5 months when they developed signicant diabetic kidney injury. Real-time quantitative PCR (qPCR) showed that the expression of Rtn1a was signicantly higher in kidneys of db/ db;eNOS / mice compared with nondiabetic db/m;eNOS / control mice (WT) (Fig. 2d). Interestingly, immunostaining of
RTN1A was more pronounced in the glomerular area than tubular compartment of db/db;eNOS / mice compared with
WT mice (Fig. 2e), which is consistent with the observation that diabetic mice have more injury in their glomeruli than tubules. Furthermore, expressions of Rtn1a mRNA and protein were also higher in kidneys of mice killed at 10 days after unilateral ureteral obstruction (UUO) and at 4 weeks after injection of folic acid (folic acid-induced nephropathy) compared with their respective controls (Supplementary Figs 6 and 7). Since the UUO mainly induces tubular cell injury, the staining was limited only to the tubular compartments. To further conrm the specicity of the RTN1A staining, we used a second rabbit polyclonal
antibody against mouse RTN1A from a different source (CD Creative Diagnosis, Cat# DPABT-H23572). As shown in the Supplementary Fig. 8, we found a similar pattern of staining in the kidneys from mouse HIV, diabetic and UUO models using this new antibody as compared with those with the previous antibody from Abcam. These ndings in multiple murine models, together with the previous data in human CKD, strongly suggest that RTN1A specically increases in sites of renal injury in CKD, irrespective of the aetiology of the disease.
Role of RTN1A in ER stress of kidney cells. Since RTN1A is an ER-associated protein and RTN1C has been shown previously to be involved in ER stress in neuronal cells12, we examined whether RTN1A also mediates ER stress response in kidney cells using overexpression and knockdown approaches. First, we conrmed the efciency of the overexpression and short hairpin RNA (shRNA) knockdown constructs in HEK293T cells. Using an
4 NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841 ARTICLE
RTN1A expression construct, we successfully overexpressed RTN1A in HEK293T cells (Supplementary Fig. 9a,b). We also screened four different clones of shRNAs for RTN1A knockdown, and shRNA CL-1 and CL-4 were selected based on the degree of knockdown by western blot analysis (Supplementary Table 4; Supplementary Fig. 9c). In addition, we conrmed that these shRNAs knocked down only RTN1A isoform but not RTN1C (Supplementary Fig. 9c). The level of RTN1B was undetectable using currently available antibodies that detect all isoforms. We then used the RTN1A overexpression and knockdown approach to determine the role of RTN1A in ER stress in HK2 cells. By western blotting, we found that the overexpression of RTN1A increases PERK phosphorylation and expression of GRP78 and
CHOP in HK2 cells (Fig. 3a). This increase in PERK phosphorylation by RTN1A overexpression was prevented by pretreatment with an inhibitor of ER stress, 4-phenylbutyrate (4-PBA) (Fig. 3b). Tunicamycin, which is a mixture of nucleoside antibiotics known to induce unfolded protein response and trigger ER stress in eukaryotic cells, induced RTN1A expression and PERK phosphorylation. Conversely, knockdown of RTN1A prevented tunicamycin-induced phosphorylation of PERK (Fig. 3c; densitometric analysis of the western blots are shown in the Supplementary Fig. 10). In addition, the overexpression of RTN1A increased the expression of ER stress markers in HK2 cells (GRP78 and CHOP), which were abolished by pretreatment with 4-PBA (Fig. 3df). We also conrmed that tunicamycin
a b c
Vector
RTN1A
RTN1A p-PERK t-PERK
RTN1A p-PERK t-PERK
RTN1A p-PERK t-PERK
-Actin
GRP78
CHOP -Actin
-Actin
4-PBA 0 mM 0 mM 1 mM 2 mM 5 mM Scramble
shRNA-RTN1A
Tunicamycin
+ + +
+ +
Vector
RTN1A
+
+
+
+
+
d e f
RTN1A
RTN1A
GRP78
GRP78
CHOP
CHOP
Fold change of tested gene
expression relative to vector
4
3
2
1
0
Vector
* *
*
Fold change of tested gene
expression relative to vector
2.52.01.51.00.50.0
Fold change of tested gene
expression relative to vector
2.52.01.51.00.50.0
*
RTN1A
RTN1A+PBA 1 mM
RTN1A+PBA 2 mM
RTN1A+PBA 5 mM
Vector
RTN1A
RTN1A+PBA 1 mM
RTN1A+PBA 2 mM
RTN1A+PBA 5 mM
Vector
RTN1A
RTN1A+PBA 1 mM
RTN1A+PBA 2 mM
RTN1A+PBA 5 mM
g h i
Fold change of tested gene
expression relative to
vector+DMSO
1.5
1.0
0.5
0.0
Fold change of tested gene
expression relative to
vector+DMSO
10
8 6 4 2 0
Fold change of tested gene
expression relative to
vector+DMSO
15
10
5
*
*
*
# #
#
Vector+DMSO
shRNA+DMSO
Vector+Tm
shRNA+Tm
Vector+DMSO
shRNA+DMSO
Vector+Tm
shRNA+Tm
Vector+DMSO
0 shRNA+DMSO
Vector+Tm
shRNA+Tm
Figure 3 | Role of RTN1A in ER stress. (a) HK2 cells were transfected with RTN1A or control vector for 3 days. Representative western blots for RTN1A, p-PERK, T-PERK (total PERK), GRP78, CHOP and b-actin are shown. (b) HK2 cells transfected with RTN1A were treated with an ER stress inhibitor 4-PBA at 0, 1, 2 and 5 mM. Representative western blots of RTN1A, p-PERK, T-PERK and b-actin are shown. (c) HK2 cells infected with a lentivector containing either scramble shRNA or RTN1A-shRNA were stimulated with tunicamycin (Tm) at 25 ng ml 1 or DMSO as control for 24 h. Representative western blots of RTN1A, p-PERK, T-PERK and b-actin are shown. (df) HK2 cells transfected with RTN1A or control vector were treated with an ER stress inhibitor 4-PBA at 0, 1, 2 and 5 mM. Real-time qPCR analyses for RTN1A and genes involved in ER stress markers (GRP78 and CHOP) were performed.
*Po0.05, compared with vector group, DPo0.05, compared with RTN1A group, n 3. (gi) HK2 cells infected with either a lentivector containing
scramble (vector) or RTN1A-shRNA (shRNA) were stimulated with DMSO or tunicamycin (Tm) for 24 h. Real-time PCR analysis for RTN1A and genes involved in ER stress markers (GRP78 and CHOP) were performed. *Po0.05 compared with vector DMSO group, #Po0.05 compared with vector Tm
group, n 3. Each PCR experiment was performed in triplicate and western blots were performed in duplicate. The data were expressed as means.d.
The ANOVA with Bonferroni correction was used.
NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 5
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841
signicantly induced the mRNA expression of RTN1A as well as markers of ER stress (GRP78 and CHOP) in HK2 cells, which were attenuated by knockdown of RTN1A (Fig. 3gi). We then examined the time course of the effects of RTN1A overexpression on the expression of ER stress markers (Supplementary Fig. 11a) and the expression of the CHOP target genes in RTN1A-overexpressing cells (Supplementary Fig. 11b). These data further conrmed the role of RTN1A in ER stress response in the kidney cells.
Role of RTN1A in apoptosis of HK2 cells. Since prolonged ER stress leads to apoptosis and previous studies suggested that RTN1 is involved in the induction of apoptosis of neuronal cells11,12, we assessed whether RTN1A mediated apoptosis of kidney cells. We found that overexpression of RTN1A-induced apoptosis of HK2 cells, as detected by Annexin V labelling (Fig. 4a,b) and Caspase-3 activation based on cleavage and activity (Fig. 4ce). In contrast, inhibition of ER stress by 4-PBA attenuated RTN1A-induced apoptosis in HK2 cells, suggesting that RTN1A induces apoptosis through ER stress (Fig. 4ae). Since 4-PBA may have some nonspecic effects, we further conrmed that RTN1A-induced ER stress is blocked by shRNA-mediated knockdown of CHOP (Fig. 4fi). Furthermore, knockdown of RTN1A also attenuated tunicamycin-induced apoptosis in HK2 cells (Supplementary Fig. 12). Taken together, these data suggest that RTN1A plays a key role in ER stress-induced apoptosis of kidney cells.
RTN1A mediates high glucose-induced ER stress in HK2 cells. Since high glucose is known to induce ER stress in kidney cells17, we examined whether RTN1A is required for high-glucose-induced ER stress in HK2 cells. We found that high glucose induced the expression of RTN1A and ER stress markers (GRP78 and CHOP) in HK2 cells compared with cells treated with mannitol of the same osmolarity (Fig. 5ad). Knockdown of RTN1A attenuated high-glucose-induced increase in RTN1A expression (Fig. 5a,b) and ER stress marker expression (Fig. 5c,d). Furthermore, we found that RTN1A knockdown inhibited the high-glucose-induced apoptosis of HK2 cells, as assessed by the measurement of Caspase-3 activity by enzyme-linked immunosorbent assay (Fig. 5e) and ow cytometry analysis using Annexin V (Fig. 5f,g). To understand how high glucose induces RTN1A expression, we treated HK2 cells with either normal glucose, normal glucose with mannitol, high glucose together with or without inhibitor of reactive oxygen species (N-acetylcystein), or inhibitor of NOX (VAS2870). We found that the inhibition of reactive oxygen species by either N-acetylcystein or VAS2870 inhibited high-glucose-induced RTN1A expression, suggesting that high glucose induces RTN1A expression likely through the activation of oxidative stress pathway (Fig. 5h,j).
RTN1A mediates high-glucose-induced ER stress in podocytes. In addition to renal tubules, we examined the effects of RTN1 overexpression in podocytes. Human podocytes were transfected with control or RTN1A overexpression vector for 3 days and expression of ER stress markers were determined by western blot. Overexpression of RTN1A in podocytes also induced ER stress, as demonstrated by increased expression of ER stress markers (GRP78 and CHOP) (Supplementary Fig. 13a). Conversely, knockdown of RTN1A expression attenuated high-glucose-induced ER stress, as assessed by decreased GRP78 and CHOP expression in podocytes (Supplementary Fig. 13bd), suggesting that RTN1A mediates ER stress in podocytes.
RTN1A N- and C-terminal domains are required for ER stress. RTN1 has two unusually long hydrophobic regions, separated by a 66 amino-acid long, hydrophilic loop and followed by a short C-terminal tail (as depicted in Supplementary Fig. 14). RTN1A, RTN1B and RTN1C share the same C-terminal domain, which is well-conserved in all reticulon proteins18, but vary in the length of their N-terminal regions, which also varies markedly between the reticulon proteins. While RTN1C has extremely short N-terminal sequences, RTN1A has a much longer N-terminal region (RTN1A is about 400 amino-acids longer than RTN1B) that is likely to confer specic biological functions. Somewhat surprisingly, no recognizable protein domains have been identied so far in the N-terminal regions19. Our studies suggest that among three RTN isoforms only RTN1A is induced in the diseased kidney and mediates ER stress and apoptosis in kidney cells. To explore how RTN1A induces ER stress in kidney cells, we made several constructs of RTN1A for in vitro functional studies. In addition to the full-length RTN1A construct (WT-RTN1A), we made a mutant construct of RTN1A with the deletion of its C-terminal domain (MT-RTN1A) and a construct for RTN1C isoform, which has a very short N-terminal domain. We then performed an immunoprecipitation (IP) assay to determine whether these RTN1A proteins interact with ER stress protein PERK. Interestingly, we found that while full-length WT-RTN1A interacts with PERK, neither MT-RTN1A nor RTN1C did not (Fig. 6a). These ndings suggest that both N-terminal and C-terminal domains of RTN1A are required for its interaction with and possibly to activate PERK. In addition, we conrmed the interaction of RTN1A with PERK in kidney cells by co-IP with endogenous protein (Fig. 6b). Since endogenous RTN1A expression is low, we performed the IP of RTN1A with PERK in cells stimulated with tunicamycin to induce RTN1A expression (Fig. 6b). Furthermore, WT-RTN1A induced the expression of ER stress markers as measured by both real-time PCR (Fig. 6c,d) and western blot (Fig. 6e) analyses of GRP78 and CHOP, while MT-RTN1A or RTN1C did not. We also found that overexpression of the MT-RTN1A or RTN1C had much less effects on apoptosis of HK2 than overexpression of WT-RTN1A, as assessed by Annexin V ow cytometry (Fig. 6f,g) and measurement of Caspase-3 activity (Fig. 6h). These data suggest that both N-terminal and C-terminal domains of RTN1A are required for RTN1A-induced apoptosis of kidney cells. In the future studies, we will further determine how the interaction between RTN1A and PERK induces ER stress and apoptosis in renal cells.
Role of RTN1 in animal models of kidney disease. To determine the functional role of RTN1 in vivo in kidney disease, a doxycycline (DOX)-inducible RNA interference (RNAi) model was developed20 for Rtn1a as described in Methods. We generated mice with DOX-inducible widespread Rtn1a knockdown and a green uorescent protein (GFP) reporter under the control of the strong synthetic CAGs (cytomegalovirus early enhancer element and chicken beta-actin) promoter, called CAGs;Rtn1RNAi mice. We compared RTN1A protein and mRNA expression in the kidney cortex of CAGs;Rtn1RNAi mice with and without DOX feeding (625 mg kg 1 chow for 3 weeks starting at 6 weeks of age) and showed that DOX feeding reduced RTN1A expression but not that of RTN1C. We could not detect RTN1B in the kidney using available antibodies. We have generated two lines of CAGs;Rtn1RNAi mice (Rtn1_353 and Rtn1_713 mice) (Supplementary Figs 15 and16). DOX feeding also increased the GFP expression in both lines. The Rtn1a_353 line was used in all subsequent experiments and Rtn1_713 line was used for validation experiments. To control for nonspecic responses due to DOX feeding and shRNAmir
6 NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841 ARTICLE
a b
Vector RTN1A
RTN1A+4-PBA
105
105
105
Apoptotic cells (%)
104
104
104
PI
103
103
103
#
102
102
102
0
0
0
0
102
103
104
105
0
102
103
104
105
0
102
103
104
105
RTN1A+4-PBA
Annexin V Annexin V Annexin V
25
20
15
10
5
0 Vector
c d e
3
2
1
* *
*
Active caspase 3 (ng mg1 )
Active caspase 3 (ng mg1 )
RTN1A
Cleaved
Caspase 3
Cleaved
Caspase 3
Densitometry for cleaved
caspase 3 to -actin
#
#
0.40.30.20.10.0
#
#
-actin 4-PBA:
0 mM
0 mM
1 mM
2 mM
5 mM
RTN1A+4-PBA (0)
RTN1A+4-PBA (1 mM)
0 RTN1A+4-PBA (2 mM)
Vector
RTN1A
RTN1A+4-PBA (5 mM)
Vector
RTN1A
Vector
RTN1A
RTN1A+4-PBA
f
CHOP GAPDH
GAPDH
WT
Scr
Scr
Scr+RTN1A
h i
Densitometry for cleaved
caspase 3 to -actin
4
3
2
1
g
10.80.60.40.2 0
Clone1
Clone2
Clone3
Clone4
Clone5
Clone6
*
*
#
# #
Scr RTN1A+CHOP-shRNA3
Scr+RTN1A
#
#
RTN1A+4-PBA
RTN1A+CHOP-shRNA2
RTN1A+CHOP-shRNA3
0 RTN1A+4-PBA
RTN1A+CHOP-shRNA2
RTN1A+CHOP-shRNA2
Scr
Scr+RTN1A
RTN1A+CHOP-shRNA3
Figure 4 | Role of RTN1A in apoptosis of HK2 cells. (a) Flow cytometric analysis of HK2 cells for apoptosis after double labelling with Annexin V and propidium iodide. HK2 cells were transfected with a RTN1A expression vector (RTN1A) or an empty vector (Vector) by electroporation 5 days before the apoptosis study. RTN1A-overexpressing cells were treated with or without 4-PBA at 5 mM 24 h post-transfection. (b) Summary of apoptosis data on HK2 cells. *Po0.01 compared with vector, #Po0.05 compared with RTN1A cells, n 3. (c,d) Western blots and densitometry analysis conrmed that cleavage
of Caspase-3 was increased in RTN1A overexpressed HK2 cells and inhibited by 4-PBA treatment (0, 1, 2 and 5 mM). (e) Caspase-3 activity was measured by enzyme-linked immunosorbent assay in HK2 cells transfected with RTN1A construct or vector for 5 days. RTN1A-overexpressing cells were treated with or without 5 mM 4-PBA for 24 h post-transfection. *Po0.05 compared with vector, #Po0.05 compared with RTN1A cells, n 3. (fi) RTN1A-induced ER
stress was inhibited by knockdown of CHOP using specic shRNA. The efciency of knockdown was conrmed by western blot analysis (f). On the basis of these data, shRNA#2 and shRNA#3 were selected. Using these shRNA, we conrmed that knockdown of CHOP attenuated RTN1A-induced apoptosis as assessed by western blot analysis of cleaved Caspase-3 (g), which is conrmed by densitometry analysis (h). This was also conrmed by measurement of Caspase-3 activity in these cells (i). *Po0.01 when compared with scramble shRNA, #Po0.01 when compared with scramble shRNA RTN1A
overexpression, n 3. Each experiment of ow cytometry was performed in duplicate. Western blot was performed in triplicate. The data were expressed
as means.d. The two-sided unpaired t-test or ANOVA was used where are appropriate.
expression, CAGs;LucRNAi mice that expresses an shRNAmir guide sequence against the rey luciferase gene20 were used as controls in subsequent animal studies.
Both CAGs;Rtn1RNAi (shRNA) and CAGs;LucRNAi (WT) mice were fed with DOX from 6 to 9 weeks of age and then either the UUO or sham operation was performed at 9 weeks of age (n 6;
3 females and 3 males). Mice were killed 10 days after the surgery. There were no changes in body weight and urine albumin/
creatinine ratio between baseline (prior DOX feeding), day of surgery or 10 days post-surgery (Supplementary Fig. 17). Both mRNA and protein levels of RTN1A increased in the UUO kidney compared to sham-operated kidney in the control mice. However, Rtn1a expression was suppressed in the UUO kidney of shRNA mice compared with the UUO kidney of control mice (Fig. 7c,d). Interestingly, renal brosis was signicantly attenuated in the kidney of shRNA UUO mice as compared with those
NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 7
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841
of control UUO mice (Fig. 7a,b). In addition, while PERK phosphorylation and expression of ER stress markers were increased in the kidney of control UUO mice, these were also attenuated in the kidney of shRNA UUO mice (Fig. 7ce),
suggesting that knockdown of Rtn1a expression improves renal brosis and ER stress in the UUO kidney. To conrm that the observed effects were not due to the off-target effects of shRNA, we validated these ndings in another line of Rtn1a knockdown
a
RTN1A
GAPDH
Sc-con
Sc-HM
Sc-HG
shRNA-con
shRNA-HM
shRNA-HG
b c d
RTN1A
GRP78
CHOP
Fold change of tested gene
expression relative to
Sc-control
2.01.51.00.50.0
Fold change of tested gene
expression relative to
Sc-control
2.01.51.00.50.0
2.01.51.00.50.0
*
* *
# #
Fold change of tested gene
expression relative to
Sc-control
#
Sc-con
Sc-HM
Sc-HG
shRNA-con
shRNA-HM
shRNA-HG
Sc-con
Sc-HM
Sc-HG
shRNA-con
shRNA-HM
shRNA-HG
Sc-con
Sc-HM
Sc-HG
shRNA-con
shRNA-HM
shRNA-HG
e
Active caspase
concentration (ng/ml)
0.80.60.40.20.0
*
# #
#
C HM HG C HM HG
Scr shRNA-RTN1A
f
g
105
*
PI
PI
12
8
4
104
104
104
104
103
103
PI
103
PI
103
% of apoptotic cells
#
102
102
102
102
0
0
0
0
0 Scr + HG
shRNA-RTN1A+HM
shRNA-RTN1A+HG
0
102
103
104
105
0
102
103
104
105
0
102
103
104
105
0
102
103
104
105
Annexin V
105
Annexin V
Scr + HM Scr + HG shRNA + HM shRNA + HG
Scr + HM
Annexin V
105
Annexin V
105
h
Fold changes of RTN1A/GAPDH
mRNA ratio related to control
32.5 2
1.5 1
0.5 0
*
# #
j
*
HM HG HM+NAC
#
C
C+NAC
C+VAS
HM+VAS
HG+NAC
HG+VAS
Densitometry (fold change of
RTN1A/GAPDH to control)
#
C
HG+NAC
HM HG HM+NAC
i
RTN1A
GAPDH
C HM HG C HM HG C HM HG Control NAC VAS
32.5 2
1.5 1
0.5 0
C+NAC
C+VAS
HM+VAS
HG+VAS
8 NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841 ARTICLE
mice (Rtn1_713 line) and conrmed that knockdown of Rtn1a indeed attenuates renal brosis and ER stress marker expression in the UUO kidney (Supplementary Fig. 19).
To assess whether RTN1A could be considered as a potential drug target for therapy, we next determined whether the knockdown of Rtn1a following kidney injury also attenuates kidney brosis and expression of ER stress markers. We fed the mice with DOX from post-UUO day 3 to initiate Rtn1a knockdown after kidney injury was established. As shown in Fig. 8, Rtn1a knockdown following the renal injury in vivo attenuated renal brosis and ER stress in the UUO kidneys, indicating that the inhibition of RTN1A expression is protective against kidney disease progression.
To conrm a local and direct role of RTN1A in renal tubular cells, we crossed Pax8-reverse tetracycline transactivator (Pax8-rtTA) mice with Rtn1RNAi mice to generate a tubular epithelial cell-specic Rtn1a knockdown mouse model. In this model, we also conrmed that knockdown of Rtn1a in tubular cells attenuated renal brosis and ER stress in the UUO kidney (Fig. 9).
Finally, we examined whether knockdown of Rtn1a affects the progression of DN. Both CAGs;Rtn1RNAi (shRNA) and CAGs;LucRNAi (WT) mice were injected intraperitoneally with low doses of streptozotocin (STZ) to induce diabetes at 8 weeks of age (n 6; 3 females and 3 males). Blood glucose levels were
monitored weekly. Mice were fed with DOX from 10 to 24 weeks of age when they were killed. Compared with nondiabetic WT mice, diabetic WT mice developed signicant albuminuria, kidney and glomerular hypertrophy, and mesangial expansion, which are typically seen in early DN. However, diabetic shRNA mice had attenuated albuminuria, kidney and glomerular hypertrophy, and mesangial expansion compared with diabetic WT mice (Supplementary Table 5; Fig. 10ac), suggesting that the knockdown of Rtn1a also prevented the development of early DN in diabetic mice. In addition, we found that expression of Rtn1a and ER stress markers was induced in diabetic WT mice but inhibited in diabetic shRNA mice (Fig. 10d). These data suggest that knockdown of Rtn1a expression prevents early DN likely through inhibition of diabetic-induced ER stress in kidney cells. Future studies are required to determine whether knockdown of Rtn1a expression halts the progression of kidney disease in an animal model with progressive DN.
DiscussionDespite optimal medical therapy, many patients with CKD progress to end-stage renal disease4. Therefore, it is critical to identify the underlying mechanisms mediating progression of kidney disease. In the current study, we used the Tg26 model as an experimental model of CKD to identify candidate genes that may be important for the development and progression of nephropathy. Since Tg26 mice exhibit variable severity of renal
phenotypes ranging from rapid progression to renal failure (over 23 months) to mild disease with stable renal function for 46 months, it is an ideal system for studying factors that dictate kidney disease progression13. We identied a cluster of genes that were upregulated in kidneys with more severe kidney disease. This list included several interesting genes, some of which are known to be involved in the pathogenesis of CKD. We selected RTN1 as a priority gene for our study for following reasons: (1) by searching the publically available data sets from Nephromine.org, we found that RTN1 was highly expressed in human diabetic kidney and correlated with the progression of human DN; (2) previous studies in the neurons suggested that RTN1 might be involved in ER stress and apoptosis, which are key pathologic processes leading to the progression of DN; and (3) RTN1 has never been studied in the context of kidney disease. In this study, we were able to validate the increased expression of RTN1A in human DN and HIVAN as well as in several animal models of kidney disease, indicating that RTN1A function is involved in general progression of CKD.
On injury, upregulation of RTN1A is found predominantly in the tubulointerstitial compartment including both tubular and interstitial cells. However, glomerular expression of RTN1A was also present and was associated with increased glomerular injury. These data suggest that RTN1A plays a role in both glomerular and tubular cell injury. Increased RTN1A expression is also found in interstitial cells, suggestive of its possible role in renal inammation, which would be an important avenue to explore in future studies. Consistent with the transcriptomic data from patients with DN16, we conrmed that increased RTN1A protein expression in the tubulointerstitial compartment correlated with decreased kidney function in an independent cohort of patients with DN. These data strongly support a role for RTN1A in the progression of human DN.
RTNs have previously been examined in the context of neurodegenerative diseases59,21,22 and are known to be involved in endocytosis10 and initiation of apoptosis through regulation of ER stress in neuronal cells11,12. However, a biologic function of RTN1A has not been well characterized. Here we demonstrated that RTN1A plays a key role in ER stress and apoptosis of kidney cells. Our results suggest that RTN1A mediates high-glucose-induced ER stress and apoptosis of kidney cells. In addition, we found that high glucose induces RTN1A expression in kidney cells through the activation of oxidative stress pathway. These data suggest that RTN1A could be important for hyperglycaemia-induced tubular injury and progression of renal injury in kidney diseases.
To understand how RTN1A contributes to ER stress, we examined the interaction of RTN1A with PERK, a key ER stress molecule leading to the activation of apoptosis pathway. Interestingly, we found that only WT-RTN1A interacted with PERK, whereas MT-RTN1A or RTN1C did not. In addition, expression of MT-RTN1A or RTN1C was unable to induce ER
Figure 5 | RTN1A mediates HG-induced ER stress and apoptosis in HK2 cells. (a) Western blots of RTN1A using HK2 cells that were transduced with lentiviral shRNA construct targeting RTN1A (shRNA) or scrambled shRNA (Sc) as control. Four days after infection, HK2 cells were incubated with normal glucose at 6 mM (no Tx) or normal glucose with equal osmolarity of mannitol (HM) or high glucose (HG) at 30 mM for an additional 24 h. (b) mRNA expression of RTN1A and (c,d) markers of ER stress as quantied by qPCR. After knockdown of RTN1A for 3 days, HK2 cells were incubated with normal glucose (C), normal glucose with equal osmolarity of mannitol (HM), or high glucose (HG) at 30 mM for an additional 3 days. The apoptosis was assessed by measurement of Caspase-3 activity using enzyme-linked immunosorbent assay (e) and ow cytometry (f,g). *Po0.05 compared with Scramble-control group, #Po0.05 compared with Scramble-HG group, n 3. To assess whether reactive oxygen species mediates HG-induced RTN1A expression, we
treated HK2 cells with C, HM and HG as above for 24 h with or without N-acetylcystein (NAC) or VAS2870 (Vas). Expression of RTN1A was assessed by qPCR (h) and western blot (i) analysis. The western blots were quantied by densitometry (j). *Po0.05 compared with control, #Po0.05 compared with
HG, n 3. Each PCR experiment was performed in triplicate. Flow cytometry and western blots were performed in duplicate. The data were expressed as
means.d. The ANOVA with Bonferroni correction was used for multiple group analysis.
NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 9
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841
a b
IP with CL-
IgG
WT-RTN1A FLAG
MT-RTN1C FLAG
RTN1C FLAG
Input
IP with
Anti-PERK
Input
Backbone
WT-RTN1A FLAG
MT-RTN1C FLAG
RTN1C FLAG
WT-RTN1A FLAG+CL-IgG
SIRT1-FLAG: input
SIRT1-FLAG: PERK IP
C T C T C T C T
kDa 130
100
70
55
35 25
Backbone
RTN1A
RTN1A
PERK
15 Input Anti-PERK IP Control
kDa 130 100
70 55
35
c d e
CHOP
* *
# # #
#
relative to backbone
Fold changes
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
GRP78 3.0
2.5
2.5
1.5
1.0
0.5
0.0
Fold changes
relative to backbone
RTN1A
RTN1C GRP78
CHOP GAPDH
Backbone
WT-RTN1A
MT-RTN1A
RTN1C
Backbone
WT-RTN1A
MT-RTN1A
RTN1C
Backbone
WT-RTN1A
MT-RTN1A
RTN1C
f
103
PI
105 104
103
102
0
105 104
103
102
0
104
PI
Backbone WT-RTN1A MT-RTN1A RTN1C 105
105
PI
105 104
103
102
0
PI
102
0
0
102
103
104
0
102
103
104
105
0
102
103
104
105
0
102
103
104
105
Annexin V
Annexin V
Annexin V
Annexin V
g h
Active caspase 3 (ng mg1 )
0.8
0.6
0.4
0.2
0
*
*
% of apoptotic cells
25 20 15 10
5 0
#
#
Backbone
RTN1A
MT-RTN1A
RTN1C
Backbone
WT-RTN1A
MT-RTN1A
RTN1C
Figure 6 | Both N and C terminals of RTN1A are required for interaction with PERK. We generated FLAG-tagged constructs of wild-type (WT) full-length RTN1A (RTN1A), C-terminal domain deletion mutant (MT-RTN1A) and RTN1C isoform, which has only C-terminal domain of RTN1A (RTN1C), which were used to determine whether C-terminal or N-terminal domain of RTN1A is required for its interaction with PERK. Including a nonrelevant FLAG-tagged construct (FLAG-Sirt1), all constructs were overexpressed in HK2 cells for 3 days. Cell lysates were then used for IP with anti-PERK antibody and immunoblotted with anti-FLAG antibody (a). For endogenous co-IP experiments (b), HK2 cells were treated with tunicamycin (T) or DMSO (C) for 24 h. Cells were lysed for IP with anti-PERK antibody and immunoblotted with anti-RTN1A antibody. Input lysates were also assessed by western blot analysis with anti-PERK antibody. HK2 cells were transfected with either WT-RTN1A, MT-RTN1A or RTN1C for 3 days were analysed by real-time quantitative qPCR (c,d) or western blot (e) for RTN1A, RTN1C, ER stress protein GRP78 and CHOP, and GAPDH. HK2 cells transfected with WT-RTN1A, MT-RTN1A or RTN1C for 5 days were used for analysis of apoptosis by ow cytometry (f,g) and measurement of Caspase-3 activity (h). *Po0.01 compared with cells transfected with the empty backbone vector, #Po0.05 compared with WT-RTN1A, n 3. Each PCR experiment was performed in triplicate. Flow
cytometry, IP and western blots were performed in duplicate. The data were expressed as means.d. The ANOVA with Bonferroni correction was used for multiple group analysis.
10 NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841 ARTICLE
a
WT-Sham WT-UUO shRNA-Sham shRNA-UUO
H&E MTC Picrosirus red % of picrosirius red area
20 16 12
8 4 0
WT-Sham
b c d
*
*
*
Rtn1-a GRP78 CHOP
Densitometry data (relative to
WT-control)
RTN1A GRP78
CHOP -Actin
WT
UUO
6 5 4 3 2 1 0
*
#
*
#
#
#
WT-UUO
shRNA-Sham
shRNA-UUO
WT-UUO
shRNA-UUO shRNA-control
shRNA
UUO
WT
control
shRNA
control
WT-control
e
mRNA levels (fold changes
relative to WT-ctrl)
9
8
7
6
5
4
3
2
1
0 WT-Sham
* *
*
Rtn1-a GRP78 CHOP
#
#
#
shRNA-Sham
WT-UUO
shRNA-UUO
Figure 7 | Rtn1a knockdown before UUO mitigates brosis and ER stress in vivo. (a) CAGs;Rtn1asiRNA (shRNA) and CAGs;LucsiRNA (WT) mice were fed with DOX for 3 weeks before the surgery. Mice were killed 10 days after the UUO or sham-operation (Ctl) and kidneys were removed for H&E, Massons trichrome (MTC) and Picrosirius red staining. The representative pictures are shown, n 6. (b) The quantitation data of Picrosirius red staining was shown,
*Po0.01 compared with respective control mice, #Po0.05 compared with WT-UUO mice, n 6. (ce) Kidney cortices of these mice were used for protein
and RNA isolation. Western blots (c) and qPCR (e) were performed to analyse expression of Rtn1a and ER stress markers in the kidney of these mice. Western blots were analysed by densitometry (d). *Po0.05 compared with WT-Ctl, #Po0.05 compared with WT-UUO, n 6. Each qPCR experiment was
performed in triplicates. The data were expressed as means.d. The ANOVA with Bonferroni correction was used.
stress and apoptosis in kidney cells, suggesting that both N and C terminals of RTN1A are required for its interaction with PERK and for its induction of ER stress and apoptosis in kidney cells. However, our ndings are not consistent with the previous reports showing that RTN1C overexpression induces ER stress
and apoptosis in neuronal cells11,12. While it is plausible that different isoforms may have cell type-specic functions, detailed mechanism of this discrepancy/inconsistency requires further studies. Future studies are also required to map the potential interactive domains between RTN1A and PERK and to
NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 11
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841
a
WT-Sham WT-UUO shRNA-Sham shRNA-UUO
MTC Picrosirius red
b c
25 20 15 10
5 0
*
*
RTN1A
GRP78
CHOP
% of picrosirius red area
WT-Sham
WT-UUO
25 20 15 10
5 0
Expression fold change
relative to WT
# * *
#
# #
shRNA-Sham
shRNA-UUO
WT-Sham
WT-UUO
shRNA-Sham
shRNA-UUO
Figure 8 | Rtn1a knockdown post-UUO attenuates renal brosis. Both CAGs;Rtn1siRNA (shRNA) and CAGs;LucsiRNA (WT) mice underwent either UUO or sham-operation and then fed with DOX 3 days after the surgery. The mice were killed at 21 days post-UUO. The kidneys were removed for histology analysis (a) and the brosis score was determined by quantication of Picrosirius staining (b). The expression of ER stress markers was analysed by qPCR (c). *Po0.01 compared with WT-Sham, #Po0.05 compared with WT-UUO, n 6. Immunostaining was performed in duplicate. The representative
pictures of six mice are shown. The data were expressed as means.d. The ANOVA with Bonferroni correction was used. MTC, Massons trichrome.
understand how this interaction leads to the activation of ER stress in kidney cells.
To conrm the role of RTN1A in the progression of kidney disease, we developed a mouse model with knockdown of Rtn1a expression by shRNA. We found that knockdown of Rtn1a expression before the surgery attenuated renal brosis and ER stress in the UUO model. We also found that the knockdown of RTN1A expression in the mice with established kidney disease also ameliorated the progression of the disease. To verify that our ndings are not a result of nonspecic off-target effects of shRNA, we validated these ndings in another line of Rtn1a knockdown mice. In addition, we showed that tubular cell-specic knockdown of RTN1A also attenuated kidney injury, indicating an important/a direct role of RTN1A in tubular cell injury. Finally, knockdown of Rtn1a also ameliorated albuminuria, kidney and glomerular hypertrophy, and mesangial expansion in STZ-induced diabetic mice, suggesting that RTN1A is involved in mediating these changes of early DN. Future studies are required to conrm whether lack of RTN1A also attenuates kidney injury in an animal model of progressive DN. Taken together, this is the rst in vivo evidence suggesting that RTN1A contributes to the development of kidney disease and that it may be a potential drug target for therapy for CKD progression.
A large body of evidence suggests that ER stress plays a major role in the development and progression of kidney disease including DN2325. High glucose concentrations induce ER stress and apoptosis of kidney cells17. Diabetic rats exhibit enhanced kidney cell apoptosis, CHOP, JNK and Caspase-12 expression26. Diabetic CHOP knockout mice seemed to be protected from DN, because they developed less proteinuria than WT control mice27. Elevated urinary protein excretion in humans is known to be associated with tubular injury and ER stress17,28,29. In humans and rats with nephrotic syndrome, ER stress markers are elevated
in tubular epithelial cells30,31. In addition, renal expression of ER stress markers in patients with established DN is higher than patients with mild DN. These results suggest an activation of ER stress response in the kidney of patients with established DN17. Over the past decade, there has been considerable interest in developing compounds that modulate ER stress response. Chemical chaperones that improve ER folding capacity, such as 4-PBA, taurine-conjugated ursodeoxycholic acid and the ER chaperone ORP150, have been shown to reduce ER stress, restore glucose tolerance and improve insulin action and sensitivity3234. 4-PBA is an aromatic short chain fatty acid that has chaperone-like activities and recent work shows that PBA attenuates kidney injury and oxidative stress in rats with DN35. Our data suggest that 4-PBA abolishes RTN1A-induced ER stress and apoptosis in HK2 cells. However, the ER stress response could have both protective and deleterious features depending on whether it is the initial adaptive response or whether prolonged and chronic. An improved understanding of the molecules regulating these processes in a cell- and disease-specic manner will help identify novel therapeutic strategies targeting ER stress to prevent the progression of kidney36disease.
In conclusion, we have shown that RTN1A expression is highly upregulated in HIVAN and DN, and that RTN1A is a key molecule mediating hyperglycaemia-induced ER stress and apoptosis of renal cells, contributing to the progression of kidney disease. Importantly, the inhibition of its expression attenuates renal brosis and diabetic kidney injury, suggesting that it may be a novel therapeutic target for treatment of CKD including DN.
Methods
Animal studies. All animal studies were approved by the IACUC committee of Mount Sinai School of Medicine. Genomic DNA extracted from tail clipping was
12 NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841 ARTICLE
a
WT-Sham WT-UUO Pax8 shRNA-Sham Pax8 shRNA-UUO
MTC Picrosirius red
% of picrosirius red area
WT-Sham
b c 12
10
6 4 2 0
RTN1A GRP78 CHOP
25 20 15 10
5 0
* *
8
*
#
#
*
# #
WT-UUO
Pax8-shRNA-Sham
Pax8-shRNA-UUO
Expression fold change
relative to WT
WT-Sham
WT-UUO
Pax8-shRNA-Sham
Pax8-shRNA-UUO
Figure 9 | Tubule-specic Rtn1a knockdown attenuates renal brosis and ER stress. To determine the specic role of RTN1A in renal tubular cells, we generated tubular cell-specic Rtn1a knockdown mice (PAX8-shRNA) by crossing Rtn1siRNA (shRNA) with Pax8-rtTA mice. PAX8-shRNA mice and their control littermates (WT) underwent UUO or sham-operation and killed 10 day after the surgery. The kidneys were removed for histology analysis (a). The renal brosis score was determined by quantication of Picrosirius red staining (b). The expression of ER stress markers was determined by real-time PCR analysis in these kidneys. *Po0.01 compared with WT-sham, #Po0.05 compared with WT-UUO, n 6. Immunostaining was performed in duplicate. The representative
pictures of six mice are shown. The data were expressed as means.d. The ANOVA with Bonferroni correction was used. MTC, Massons trichrome.
a
WT-Ctl WT-STZ shRNA-Ctl shRNA-STZ
b c d
Fold changes relative to WT-Ctl
7
6
5
4
3
2
1
*
Mesangial area %
35
30
25
20
15
10
5
Glomerular volume (105 )
3.5
3
2.5
2
1.5
1
0.5
0
*
# #
* *
*
#
#
Rtn1a GRP78 CHOP
#
WT-Ctl
0 WT-STZ
shRNA-Ctl
shRNA-STZ
WT-Ctl
WT-STZ
shRNA-Ctl
shRNA-STZ
0 WT-Ctl
WT-STZ
shRNA-Ctl
shRNA-STZ
Figure 10 | Rtn1a knockdown protects against DN development. CAGs;Rtn1asiRNA (shRNA) and CAGs;LucsiRNA (WT) mice were injected with STZto induce diabetes at age of 8 weeks. Mice were fed with DOX from 10 to 24 weeks and killed at age of 24 weeks. Urine albumin was determined (Supplementary Table 5). Kidneys were removed for histology (a) and glomerular volume (b) and mesangial area (c) were quantied. (d) Renal expression of Rtn1a and ER stress markers was determined by real-time PCR. The representative pictures of kidney histology are shown. *Po0.05 compared with nondiabetic WT mice (WT-Ctl), #Po0.01 compared with diabetic WT mice (WT-STZ), n 6. Each PCR experiment was performed in triplicates.
The data were expressed as means.d. The ANOVA with Bonferroni correction was used.
NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 13
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841
used. To detect the HIV-1 transgene (Tg26), we performed standard PCR procedures using the following primers: forward 50-ACATGAGCAGTCAGTTCTGCCG
CAGAC-30, reverse 50-CAAGGACTCTGATGCGCAGGTGTG-30. Thermo prole for the PCR reaction was as follows: 95 C for 5 min followed by 35 cycles at 95 C for 30 s, 62 C for 45 s and 72 C for 45 s, then 72 C for 10 min. Only male heterozygous Tg26 in the FVB/N background were used in the study, since homozygous Tg26 mice are not viable for more than few weeks postnatally. Male diabetic db/db, nondiabetic db/m and eNOS / mice in B6 background were obtained from Jackson Laboratory and crossed to generate db/db;eNOS / mice and litter-matched control mice. The kidneys were collected from these mice for histology, western blot, real-time PCR analysis and microarray studies. Kidney disease was conrmed by measurement of proteinuria, renal function and histo-logic analysis.
Creation of Rtn1 knockdown mouse model. We developed a DOX-inducible RNAi model20 for Rtn1. Nine shRNA guide sequences predicted to target Rtn1 for knockdown were embedded into a miR30-based expression cassette of a retroviral DOX-inducible shRNA vector. Two sequences achieved 450% knockdown compared with a control shRNA based on both real-time PCR and western blot analyses (Supplementary Figs 13 and 14). Two lines of genetically engineered mice, each corresponding to one of the two guide sequences that achieved 450%
knockdown in vitro, were generated using the ColA1 Flp/FRT recombinase-mediated targeting system. Details of construct design and transgenesis have been described previously20. Briey, the Flp-In targeting vector, called pCol-TGM, was congured with a GFP spacer between a tetracycline-regulated element and the miR30-based expression cassette. Genetically engineered KH2 embryonic stem cells were used for targeted insertion of pCol-TGM to generated TGM mice. To generate CAGs;Rtn1RNAi mice, TGM mice were bred with another line of genetically engineered mice that express the rtTA under the control of the CAGs promoter. CAGs;Rtn1RNAi mice derived from KH2 ES cells are on a hybrid genetic background with contributions from C57BL/6 and 129/SV strains. To generate renal tubular epithelial cell-specic Rtn1a knockdown mice, we crossed Pax8-rtTA mice with Rtn1RNAimice to have Pax8;Rtn1RNAimice. To induce Rtn1a knockdown mice were fed 625mg/kg DOX-supplemented chow (Bio-Serv, Frenchtown, NJ) for the duration specied in the Results and gure legends.
Creation of UUO model. To create the UUO model, the left ureter of mice was exposed through a mid-abdominal incision and ligated using 4-0 silk. Sham-operated mice had their ureters exposed and manipulated but not ligated. All surgeries were performed under general anaesthesia with isouorane. Six mice in each group were selected based on previous studies without the use of randomization and blinding37.
Creation of diabetic model by STZ injection. Induction of diabetes using STZ has been described38. Briey, 8-week-old WT and shRNA mice were given low-dose STZ (50 mg kg 1) in 50 mmol l 1 sodium citrate buffer (pH 5.4)
intraperitoneally daily for 5 days. At 2 weeks post-injection, mice were deprived of food for 6 h and fasting blood glucose level from the tail vein was measured using the One Touch Blood Glucose Monitoring System. Repeat fasting blood glucose measurements were taken every 2 weeks to verify hyperglycaemia. Diabetes mellitus was dened as sustained fasting blood glucose above 250 mg dl 1 at two distinct time points. All mice were killed at 6 months of age. Six mice in each group were selected based on our previous publication without the use of randomization and blinding38.
Urine albumin and creatinine. Twenty-four-hour urine was collected from mice using metabolic cages and urine albumin was determined using a commercial assay from Bethyl Laboratory Inc. (Houston, Texas, USA). Urine creatinine levels were measured in the same samples using the QuantiChrom Creatinine Assay Kit (DICT-500) (BioAssay Systems) according to the manufacturers instructions. The urine albumin excretion rate was expressed as the ratio of albumin to creatinine.
Kidney histology. Kidney samples were xed in 10% formalin, embedded in parafn and sectioned to 4-mm thickness. Periodic acidSchiff (PAS)-stained sections were used to assess kidney histological features. The glomerular volume and mesangial area were determined by examining PAS-stained sections using a digitizing tablet and video camera. Briey, digitized images were scanned and prole areas were traced using ImageJ. The mean glomerular tuft volume was determined from the mean glomerular cross-sectional area by light microscopy. The glomerular cross-sectional area was calculated on the basis of the average area of 30 glomeruli in each group, and glomerular tuft volume was calculated using the following equation: GV (b/k) GA3/2, where b 1.38, the shape coefcient
of spheres (the idealized shape of glomeruli) and k 1.1, the size
distribution coefcient. Also, mesangial expansion was dened as a PAS-positive and nuclei-free area in the mesangium. Quantication of mesangial expansion was based on a minimum39of 10 glomeruli per section in a blinded fashion, under 400 magnication (Zeiss AX10 microscope, Carl Zeiss Canada Ltd, Toronto,
ON, Canada). The relative mesangial area was expressed as mesangial/glomerular surface area (%).
Cell culture. HK2 and HEK293T cells were obtained from ATCC (CRL-2,190 and CRL-3,216, respectively) and cultured according to their40specications. Cells were stimulated with TM (Sigma-Aldrich) with or without 4-PBA (Sigma-Aldrich) as described in the legends. Conditionally immortalized human podocytes41 were obtained from Dr Moin Saleem, Bristol, UK. Cells were grown in RPMI-1,640 medium supplemented with 10% fetal bovine serum and 1% penicillin streptomycin antibiotics. Cells were cultured on rat tail collagen-I-coated plates and maintained at 33 C (5% CO2, 90% humidity). Before experiments, cells were moved to a 37 C incubator and cultured for at least 7 days to fully induce differentiation. Endotoxin-free human serum albumin was used (Sigma). Endotoxin levels in preparations were further determined by Associates of Cape Cod (Falmouth, MA, USA) and were found to be o2 endotoxin units per mg of protein.
Transfection. The Lonzas Nucleofector Technology (Amaxa Basic Neucleofector kit for Primary Mammalian Epithelial Cells, Program T20) was used to transfect overexpression and shRNA knockdown constructs into HK2 cells with an efciency of 8090% based on GFP expression42. HEK293T cells were transfected using PolyJet transfection reagent (SignaGen Laboratories). Overexpression vector of RTN1A was obtained from Thermo Scientic and different clones of shRNA for RTN1 were obtained from Open Biosystems. The efciency of overexpression and knockdown were conrmed by both western blot and real-time PCR. The expression constructs for WT-RTN1A-FLAG, MT-RTN1A-FLAG with deletion of C-terminal domain (amino acid 1727), and RTN1C-FLAG were generated using a PCR-based mutagenesis method. To generate the human RTN1A-FLAG WT construct, we used the following primers:
50-TGCTAGCCACCATGGCCGCGCCGGGGGATCCACAGCGAGCTCATC ATCG-30 and 50-AGGTCGACATCGATTATTTGTCATCGTCGTCCTTGTAGTC CATGATATCCTCAGCGTGCCTCTTAGC-30. The FLAG sequence is shown in italic, introduced restriction enzyme sites is in bold and stop code is in underline. The PCR products were puried and then ligated into pGEM-T easy Vector (Promega). After amplication, the DNA fragment was excised from the pGEM-T easy with NheI and NotI and then ligated into pEGFP-N1 (Clontech) at the same restriction enzyme sites. For MT-RTN1A, the primers used are: 50-TTACTCGAG
TTCCAACCAAAGTCCTG-30 and 50-TTTGATATCAGCCATGAGCAGCAGG GTCAG-30. For cloning human RTN1C-FLAG, the primers used are 50-TAGCT AGCCACCATGCAGGCCACTGCCGATTCCACCAAGATGGACTGTGTGTG GAGCAACTGGAAAAGTCAGGCTATTGACCTGTTGTATTGG-30.
Lentiviral preparation and infection. HEK293T cells were transfected with either lentiviral plasmid expressing RTN1 shRNA sequence pGIPZ-shRTN1 (Open bio-systems) or control scrambled sequence, pGIPZ-scramble, plus psPAX2 packaging plasmid and pMD2.G envelop plasmid using PolyJet transfection reagent according to the manufacturers protocol (SignaGen Laboratories). Forty-eight hours after transfection the lentiviral particles were harvested from HEK293T cell culture medium. Concentrated lentiviral particles were used to infect HK2 cells or podocytes.
Apoptosis analysis. Apoptosis was measured by ow cytometry using Annexin V-FITC apoptosis detection kit (BD Bioscience). Annexin V-FITC staining detects early stage apoptosis. Necrotic or late-stage apoptotic cells were labelled by propidium iodide. The number of cells labelled with Annexin V-FITC and propidium iodide was quantied using the FACS Caliber Flow cytometer and the data were analysed with CellQuest software (BD Biosciences). Caspase-3 activity was measured in HK2 cells using a Human Active Caspase-3 Immunoassay Kit (R&D Systems, Inc.) following the manufacturers protocol.
Real-time PCR. Samples were stored in RNAlater (Qiagen) solution at 80 C
until processing. Total RNA was extracted from isolated glomeruli or cultured podocytes using RNeasy Mini Kit (Qiagen). Superscript III First-Strand Synthesis SuperMix (Invitrogen) was used for reverse transcription of 1 mg of total RNA. PCR was performed using SYBR Green Master Mix (Applied Biosystems) and the Applied Biosystems 7500 Real-time PCR system. Intron-spanning primer sets selectively targeting mRNA and not genomic DNA sequence were designed using Primer-BLAST (NCBI) (Supplementary Table 6). The homogeneity and the size of PCR amplicons were conrmed by both melting curve analysis and agarose gel electrophoresis. Data were analysed by the 2 DDCT method43 and presented as fold change relative to a control sample after normalization against the expression of a housekeeping gene.
Western blot. Tissue or cells were lysed with a buffer containing 1% NP40, a protease and phosphatase inhibitor cocktail. After protein concentration determination, cell lysates were44subjected to western blot analysis using specic antibodies (Supplementary Table 7).
14 NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841 ARTICLE
Immunoprecipitation. HK2 cells were transfected with FLAG-tagged WT-RTN1A, MT-RTN1A or RTN1C for 3 days. Cells were lysed with above lysis buffer and incubated with anti-PERK antibody (Cell Signaling) for overnight at4 oC and the precipitated materials were used for western blot analysis using anti-FLAG antibody (Sigma). For co-IP with endogenous protein, HK2 cells were treated with tunicamycin at 25 ng ml 1 or dimethylsulphoxide as control for 24 h.
Then, cells were lysed as above and incubated with anti-PERK antibody for IP and then western blot analysis with anti-RTN1A antibody as above.
Microarray studies. Affymetrix gene expression microarrays were performed at the Mount Sinai Institution Microarray Core Facility. The Affymetrix GeneChip Mouse Genome 430 2.0 Array was used to prole gene expression in the kidney cortex of Tg26 and WT mice37. One-way ANOVA was applied to the data set to identify the genes that were differentially expressed between the two groups.
P values were corrected using BenjaminiHochberg false discovery rate with a threshold of 0.05. Microarray data have been deposited in NCBI GEO under accession code GSE69074.
Immunostaining of kidney sections. Archival human kidney biopsies were collected at Jacobi Medical Center and Mount Sinai Hospital under protocols approved by their Institutional Review Boards. Biopsy samples included 5 cases of HIVAN, 5 MCD, 18 DN and 7 normal tissues from nephrectomy samples. Five samples were used to detect the average expression level of RTN1A in the specic kidney disease. More DN patients were selected from both Jacobi Medical Center and Mount Sinai Hospital for establishing a correlation between RTN1A expression and the severity of kidney disease in this patient population. We obtained only seven normal tissues from nephrectomy samples. Immunostaining was performed using specic primary antibodies (Supplementary Table 7) and biotinylated secondary antibodies (Vector Laboratories Inc.). Staining was revealed with avidin peroxidase (VECTASTAIN Elite; Vector Laboratories Inc.). Slides were mounted in Aqua Poly/Mount (Polysciences Inc.) and photographed under an Olympus BX60 microscope with a digital camera. The following antibodies were used: RTN1A (Abcam). The extent of kidney staining in human biopsies was semi-quantitatively scored. The staining of each glomerulus was scored in a scale of 04 by two independent investigators (score 0: absence of specic staining; score 1: o25% area has specic staining for RTN1A; score 2: 2550%; score 3: 5075%; and score 4: 475%). The average score of an individual patient was calculated by adding of all scores from individual glomeruli divided by the number of glomeruli in the kidney section. The average score of RTN1A staining and eGFR or Scr from individual patients were used for calculation of correlation in patients with DN using the Pearson and Spearman method.
Statistical analysis. Data expressed as means.d. (Xs.d.). The two-sided unpaired t-test was used to analyse data between the two groups after determination of data distributions and variance. The ANOVA with Bonferroni correction was used when more than two groups were present. Statistical signicance was considered when Po0.05.
References
1. Coresh, J. et al. Prevalence of chronic kidney disease in the United States. JAMA 298, 20382047 (2007).
2. Lewis, E. J., Hunsicker, L. G., Bain, R. P. & Rohde, R. D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N. Engl. J. Med. 329, 14561462 (1993).
3. Brenner, B. M. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345, 861869 (2001).
4. de Zeeuw, D. Unmet need in renal protection--do we need a more comprehensive approach? Contrib. Nephrol. 171, 157160 (2011).
5. Masliah, E. et al. Genetic deletion of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes in amyloid precursor protein transgenic mice. Neuroscience 169, 488494 (2010).
6. Heath, J. E. et al. Widespread distribution of reticulon-3 in various neurodegenerative diseases. Neuropathology 30, 574579 (2010).
7. Abdesselem, H., Shypitsyna, A., Solis, G. P., Bodrikov, V. & Stuermer, C. A. No Nogo66- and NgR-mediated inhibition of regenerating axons in the zebrash optic nerve. J. Neurosci. 29, 1548915498 (2009).
8. Xiang, R. & Zhao, S. RTN3 inducing apoptosis is modulated by an adhesion protein CRELD1. Mol. Cell. Biochem. 331, 225230 (2009).
9. Liu, Y. et al. Reticulon RTN2B regulates trafcking and function of neuronal glutamate transporter EAAC1. J. Biol. Chem. 283, 65616571 (2008).10. Iwahashi, J. & Hamada, N. Human reticulon 1-A and 1-B interact with a medium chain of the AP-2 adaptor complex. Cell. Mol. Biol. (Noisy-le-grand) 49 Online Pub OL467OL471 (2003).
11. Fazi, B. et al. Acetylation of RTN-1C regulates the induction of ER stressby the inhibition of HDAC activity in neuroectodermal tumors. Oncogene 28, 38143824 (2009).
12. Di Sano, F., Fazi, B., Tu, R., Nardacci, R. & Piacentini, M. Reticulon-1C acts as a molecular switch between endoplasmic reticulum stress and genotoxic cell death pathway in human neuroblastoma cells. J. Neurochem. 102, 345353 (2007).
13. Lu, T. C., He, J. C. & Klotman, P. Animal models of HIV-associated nephropathy. Curr. Opin. Nephrol. Hypertens. 15, 233237 (2006).
14. Ikee, R. et al. Involvement of transglutaminase-2 in pathological changes in renal disease. Nephron. Clin. Pract. 105, c139c146 (2007).
15. Bussolati, B., Collino, F. & Camussi, G. CD133 cells as a therapeutic target
for kidney diseases. Expert Opin. Ther. Targets 16, 157165 (2012).16. Woroniecka, K. I. et al. Transcriptome analysis of human diabetic kidney disease. Diabetes 60, 23542369 (2011).
17. Lindenmeyer, M. T. et al. Proteinuria and hyperglycemia induce endoplasmic reticulum stress. J. Am. Soc. Nephrol. 19, 22252236 (2008).
18. GrandPre, T., Nakamura, F., Vartanian, T. & Strittmatter, S. M. Identication of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403, 439444 (2000).
19. Chiurchiu, V., Maccarrone, M. & Orlacchio, A. The role of reticulons in neurodegenerative diseases. Neuromolecular Med. 16, 315 (2014).20. Premsrirut, P. K. et al. A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell 145, 145158 (2011).
21. He, W. et al. Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. Nat. Med. 10, 959965 (2004).
22. Montenegro, G. et al. Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. J. Clin. Invest. 122, 538544 (2012).
23. Cunard, R. & Sharma, K. The endoplasmic reticulum stress response and diabetic kidney disease. Am. J. Physiol. Renal. Physiol. 300, F1054F1061 (2011).
24. Morse, E. et al. TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1. Am. J. Physiol. Renal. Physiol. 299, F965F972 (2010).
25. Kimura, K., Jin, H., Ogawa, M. & Aoe, T. Dysfunction of the ER chaperone BiP accelerates the renal tubular injury. Biochem. Biophys. Res. Commun. 366, 10481053 (2008).
26. Liu, G. et al. Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease. Biochem. Biophys. Res. Commun. 370, 651656 (2008).
27. Wu, X., He, Y., Jing, Y., Li, K. & Zhang, J. Albumin overload induces apoptosis in renal tubular epithelial cells through a CHOP-dependent pathway. OMICS 14, 6173 (2010).
28. Cybulsky, A. V. Endoplasmic reticulum stress in proteinuric kidney disease. Kidney Int. 77, 187193 (2010).
29. Lee, E. K. et al. Activation of AMP-activated protein kinase inhibits albumin-induced endoplasmic reticulum stress and apoptosis through inhibition of reactive oxygen species. Nephron Exp. Nephrol. 121, e38e48 (2012).30. Wu, J. et al. Induction of diabetes in aged C57B6 mice results in severe nephropathy: an association with oxidative stress, endoplasmic reticulum stress, and inammation. Am. J. Pathol. 176, 21632176 (2010).
31. Inagi, R. et al. Involvement of endoplasmic reticulum (ER) stress in podocyte injury induced by excessive protein accumulation. Kidney Int. 68, 26392650 (2005).
32. Nakatani, Y. et al. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J. Biol. Chem. 280, 847851 (2005).
33. Ozawa, K. et al. The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes. Diabetes 54, 657663 (2005).
34. Ozcan, U. et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 11371140 (2006).
35. Luo, Z. F. et al. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation. Toxicol. Appl. Pharmacol. 246, 4957 (2010).
36. Ratnam, K. K. et al. Role of the retinoic acid receptor-alpha in HIV-associated nephropathy. Kidney Int. 79, 624634 (2011).
37. Jin, Y. et al. A systems approach identies HIPK2 as a key regulator of kidney brosis. Nat. Med. 18, 580588 (2012).
38. Mallipattu, S. K. et al. Expression of HIV transgene aggravates kidney injury in diabetic mice. Kidney Int. 83, 626634 (2013).
39. Zheng, F. et al. Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6 db/db mice. Kidney Int. 70, 507514 (2006).
40. Rosenstiel, P. E. et al. HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells. Kidney Int. 74, 10491058 (2008).
41. Saleem, M. A. et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 13, 630638 (2002).
NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 15
& 2015 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8841
42. Chuang, P. Y., Yu, Q., Fang, W., Uribarri, J. & He, J. C. Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor. Kidney Int. 72, 965976 (2007).
43. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402408 (2001).
44. He, J. C. et al. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J. Clin. Invest. 114, 643651 (2004).
Acknowledgements
J.C.H. is supported by VA Merit Award, NIH 1R01DK078897, NIH 1R01DK088541,
NIH P01-DK-56492, Chinese 973 fund 2012CB517601; P.Y.C. is supported by NIH
1R01DK098126-01A1.
Author contributions
J.C.H., K.L., P.Y.C., N.W. and W.J. designed the research project; Y.F., W.X., Z.L. and
X.L. performed the experiments; B.J. and H.X. provided the archival human kidney
samples; W.Z., C.W., Y.F. and W.X. analysed the data; and J.C.H., K.L., Y.F. and W.X.
wrote the manuscript.
Additional information
Accession codes: Microarray data have been deposited in NCBI GEO under accession
code GSE69074.
Supplementary Information accompanies this paper at http://www.nature.com/naturecommunications
Web End =http://www.nature.com/
http://www.nature.com/naturecommunications
Web End =naturecommunications Competing nancial interests: The authors declare no competing nancial interests. Reprints and permission information is available online at http://npg.nature.com/reprintsandpermissions/
Web End =http://npg.nature.com/
http://npg.nature.com/reprintsandpermissions/
Web End =reprintsandpermissions/
How to cite this article: Fan, Y. et al. RTN1 mediates progression of kidney
disease by inducing ER stress. Nat. Commun. 6:7841 doi: 10.1038/ncomms8841
(2015).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the articles Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Web End =http://creativecommons.org/licenses/by/4.0/
16 NATURE COMMUNICATIONS | 6:7841 | DOI: 10.1038/ncomms8841 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Nature Publishing Group Jul 2015
Abstract
Identification of new biomarkers and drug targets for chronic kidney disease (CKD) is required for the development of more effective therapy. Here we report an association between expression of reticulon 1 (RTN1) and severity of CKD. An isoform-specific increase in the expression of RTN1A is detected in the diseased kidneys from mice and humans, and correlates inversely with renal function in patients with diabetic nephropathy. RTN1 overexpression in renal cells induces ER stress and apoptosis, whereas RTN1 knockdown attenuates tunicamycin-induced and hyperglycaemia-induced ER stress and apoptosis. RTN1A interacts with PERK through its N-terminal and C-terminal domains, and mutation of these domains prevents this effect on ER stress. Knockdown of Rtn1a expression in vivo attenuates ER stress and renal fibrosis in mice with unilateral ureteral obstruction, and also attenuates ER stress, proteinuria, glomerular hypertrophy and mesangial expansion in diabetic mice. Together, these data indicate that RTN1A contributes to progression of kidney disease by inducing ER stress.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer